Prostaglandin E2/Ep2 Receptor Signalling Pathway Promotes Diabetic Retinopathy in a Rat Model of Diabetes

Diabetologia - Germany
doi 10.1007/s00125-018-4755-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Prostaglandin E2 Induced Aldosterone Release Is Mediated by an EP2 Receptor

Hypertension
Internal Medicine
1998English

Strain Differences in the Rat Streptozotocin‐induced Model of Diabetic Retinopathy

Acta Ophthalmologica
MedicineOphthalmology
2018English

Induction of Prostaglandin E2 Pathway Promotes Gastric Hamartoma Development With Suppression of Bone Morphogenetic Protein Signaling

Cancer Research
Cancer ResearchOncology
2009English

Modulation of Host Natural Killer Cell Functions in Breast Cancer via Prostaglandin E2 Receptors EP2 and EP4

Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer ResearchAllergyImmunologyPharmacology
2012English

Evaluation of Prostaglandin E2 and E-Series Prostaglandin Receptor in Patients With Interstitial Cystitis

Journal of Urology
Urology
2015English

Prostaglandin E2 Increases the Expression of B-Type Natriuretic Peptide Receptor Through EP1 Receptor, Ca2+ Mobilization and Protein Kinase C Signaling Pathway in Rat Calvarial Osteoblasts

JOURNAL OF HEALTH SCIENCE
2009English

Characterization of Motor Neuron Prostaglandin E2 EP3 Receptor Isoform in a Mouse Model of Amyotrophic Lateral Sclerosis

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2015English

Prevention of Diabetic Retinopathy by Intraocular Soluble FLT-1 Gene Transfer in a Spontaneously Diabetic Rat Model

International Journal of Molecular Medicine
MedicineGenetics
2007English

Identification of Prostaglandin E2 Receptor Subtype 2 as a Receptor Activated by OxPAPC

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy